Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Tumor Immunotherapy01:27

Tumor Immunotherapy

662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Strategies for Hepatocellular Carcinoma: Current Advances and Future Perspectives.

Vaccines·2026
Same author

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C.

Journal of gastroenterology and hepatology·2025
Same author

Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies.

Vaccines·2024
Same author

<i>In vivo</i> safety evaluation and tracing of arginylglycylaspartic acid-engineered phage nanofiber in murine model.

Journal of materials chemistry. B·2024
Same author

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma.

Cancers·2024
Same author

Erratum: Correction of Text in the Article "Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea".

Journal of Korean medical science·2023

Related Experiment Video

Updated: Sep 13, 2025

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

579

Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities.

Palaniyandi Muthukutty1, Hyun Young Woo2,3, So Young Yoo1

  • 1Institute of Nanobio Convergence, Pusan National University, Busan 46241, Republic of Korea.

Vaccines
|July 30, 2025
PubMed
Summary

Therapeutic vaccines offer targeted colorectal cancer (CRC) treatment by boosting anti-tumor immunity. This review explores novel vaccine platforms and strategies to overcome immune evasion for improved CRC immunotherapy outcomes.

Keywords:
clinical translationcolorectal cancerimmune evasionimmunotherapynanovaccinesneoantigenstherapeutic vaccinestumor microenvironment

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.6K

Related Experiment Videos

Last Updated: Sep 13, 2025

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

579
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

6.6K

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Colorectal cancer (CRC) remains a significant health challenge despite advances in conventional treatments.
  • Current immunotherapies, like immune checkpoint inhibitors, show limited efficacy in a large proportion of CRC patients (non-MSI-H).
  • There is a critical need for novel therapeutic strategies to enhance anti-tumor immunity in CRC.

Purpose of the Study:

  • To provide a comprehensive review of emerging therapeutic vaccine modalities for colorectal cancer.
  • To discuss the challenges of tumor immune evasion and heterogeneity in CRC.
  • To highlight innovative strategies and clinical developments in CRC therapeutic vaccines.

Main Methods:

  • Literature review of current research on therapeutic vaccines for colorectal cancer.
  • Analysis of various vaccine platforms: peptide, nucleic acid, cell-based, vector-driven, and nanotechnology.
  • Discussion of tumor microenvironment factors and immune evasion mechanisms relevant to CRC vaccine efficacy.

Main Results:

  • Therapeutic vaccines present a targeted approach with potentially lower systemic toxicity compared to traditional therapies.
  • Multiple vaccine platforms are under investigation, each with unique mechanisms to stimulate anti-tumor immune responses.
  • Strategies to overcome tumor immune evasion and heterogeneity are crucial for enhancing vaccine effectiveness.

Conclusions:

  • Therapeutic vaccines are a promising avenue for future colorectal cancer immunotherapy.
  • Overcoming tumor-specific immune barriers is key to unlocking the full potential of CRC vaccines.
  • Continued research and clinical translation are essential to integrate vaccines into standard CRC treatment protocols.